Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism
Abstract
Correspondance
Domains
Life Sciences [q-bio]
Origin : Publication funded by an institution
Loading...